CAS No. 154361-50-9 | Capecitabine
Name: Capecitabine CAS No. 154361-50-9 MF:C15H22FN3O6 MW:359.35 Purity:98% Package: 5g,25g,200g,500g,1kg Worldwide Delivery
Categories:
Other Life Science Chemicals
Email:sale06@alfachem.cn
Product introduction
Introduction and application of CAS No. 154361-50-9 | Capecitabine
Synonyms:5'-DEOXY-5-FLUOROCYTISINE;
5'-DEOXY-5-FLUORO-N-[(PENTYLOXY)CARBONYL]CYTIDINE;
Pentyl(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydr;
pentyl[1-(3,4-dihydroxy-5-methyl-oxolan-2-yl)-5-fluoro-2-oxo-pyrimidin-4-yl]aminoformate;
CAPECITABINE;
Cpecitabine;
5Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine,Ro-9-1978,Xeloda
Specification:
|
ITEMS |
SPECIFICATION |
|
CAS |
154361-50-9 |
|
MF |
C15H22FN3O6 |
|
MW |
359.35 |
|
Melting point |
110-121°C |
|
Flash point |
87℃ |
|
Density |
1.49±0.1 g/cm3 |
|
Acidity coefficient |
5.41±0.40 |
|
Color |
white to beige |
|
Solubility |
H2O: soluble 10mg/mL, transparent (heated) |
|
Form |
Powder |
|
Storage condition |
2-8°C |
Capecitabine is an antimetabolite fluoropyrimidine deoxynucleoside carbamate drug that can be converted into 5-FU in the body. It can inhibit cell division and interfere with RNA and protein synthesis. It is suitable for the further treatment of advanced primary or metastatic breast cancer that is ineffective with paclitaxel and chemotherapy regimens including anthracycline antibiotics. Mainly used for the treatment of advanced primary or metastatic breast cancer, rectal cancer, colon cancer and gastric cancer.
Package and transportation :
Package: 5g,25g,200g,500g,1kg
Transportation: by courier/ by air/ by sea
Key words:
Related Products
Related Products
Inquiry